Viewing Study NCT04777734


Ignite Creation Date: 2025-12-25 @ 2:22 AM
Ignite Modification Date: 2025-12-31 @ 7:27 PM
Study NCT ID: NCT04777734
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2022-04-29
First Post: 2021-02-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efgartigimod Expanded Access for Generalized Myasthenia Gravis
Sponsor: argenx
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module